Mesoblast Limited (MESO)
NASDAQ·Healthcare·Biotechnology
$13.28
+0.77%
Mkt Cap $1.99B
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$39.00
Range $39.00 – $39.00
Implied Upside
+193.7%
Consensus $39.00 vs current $13.28
NASDAQ·Healthcare·Biotechnology
$13.28
+0.77%
Mkt Cap $1.99B
No recent rating data.
Price Target (3 analysts)
$39.00
Range $39.00 – $39.00
+193.7%
Consensus $39.00 vs current $13.28